Founded in late 2019, Athebio is a highly innovative biotech startup on a mission to revolutionize the field of biotherapeutics. We specialize in developing advanced biotherapeutics with pharma partners based on Designed Ankyrin Repeat Proteins (DARPins) and enable the design and creation a variety of modalities including radiotherapeutics, ADCs, AAV, LNP and T cell engagers.
We explore and unlock the full therapeutic potential of repeat proteins and make it broadly available, with a commitment to scientific excellence, innovation and teamwork. Our mission is to support innovative drug developers to create next-generation biologics by providing tailor-made repeat proteins and supporting them with in-depth expertise and superb service.
Growth Opportunity: Are you ready to grow with us? At Athebio, you won’t just be an employee; you’ll be an active participant in shaping our company’s future.
Passion for Innovation: We’re seeking individuals who share our passion for innovation, excited about pushing boundaries and creating ground-breaking solutions.
Biotherapeutic Experts Welcome: If you have a strong understanding of the drug discovery process and hands-on experience in biotherapeutic production, we’d love to hear from you.
Informations clés
- 20 employés
- Grabenstrasse 11a, Schlieren
- Athebio AG
Les avantages de Athebio AG
De nouveaux emplois directement dans votre mailbox?
Il n'y a actuellement aucune offre d'emploi. Suivez cette entreprise et nous vous informerons dès que de nouveaux emplois seront disponibles.
Pas encore d'avis
Aidez les autres en partageant votre expérience avec cette entreprise en tant qu'employé ou candidat.